Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Hydroxyibuprofen-1

Hydroxyibuprofen-1

53949-53-4

DISCOVER
HYOSCYAMINE SULFATE CRS (80 MG)

HYOSCYAMINE SULFATE CRS (80 MG)

620-61-1

DISCOVER
5-Hydroxy Flunixin D3

5-Hydroxy Flunixin D3

1185088-54-3

DISCOVER
Hydrochlorothiazide 13C,D2

Hydrochlorothiazide 13C,D2

1190006-03-1

DISCOVER
4'-Hydroxy Diclofenac

4'-Hydroxy Diclofenac

64118-84-9

DISCOVER
Heliotrine N-oxide

Heliotrine N-oxide

6209-65-0

DISCOVER
Hydroxychloroquine Sulfate D4

Hydroxychloroquine Sulfate D4

1216432-56-2

DISCOVER
16beta-Hydroxystanozolol

16beta-Hydroxystanozolol

125590-76-3

DISCOVER
Hydrochlorothiazide Impurity C

Hydrochlorothiazide Impurity C

402824-96-8

DISCOVER
Hydroquinone

Hydroquinone

123-31-9

DISCOVER
3,5-Di-tert-butyl-4-hydroxybenzoic Acid

3,5-Di-tert-butyl-4-hydroxybenzoic Acid

1421-49-4

DISCOVER
Harmol

Harmol

487-03-6

DISCOVER